NCT06800651View on ClinicalTrials.gov

Trial of JMKX003142 in Participants With Rapidly Progressive Autosomal Dominant Polycystic Kidney Disease (ADPKD)

PHASE2RecruitingINTERVENTIONAL
Enrollment

135

Participants

Timeline

Start Date

March 13, 2025

Primary Completion Date

February 28, 2027

Study Completion Date

May 30, 2027

Conditions
ADPKD (Autosomal Dominant Polycystic Kidney Disease)
Interventions
DRUG

JMKX003142 will be administered orally

JMKX003142 will be administered orally

DRUG

Plcacebo

matched to JMKX003142

Trial Locations (1)

100034

RECRUITING

Peking University First Hospital, Beijing

Sponsors

Lead Sponsor

Jemincare
All Listed Sponsors
lead

Jemincare

INDUSTRY

NCT06800651 - Trial of JMKX003142 in Participants With Rapidly Progressive Autosomal Dominant Polycystic Kidney Disease (ADPKD) | Biotech Hunter | Biotech Hunter